“Impact of a Prognostic 40-Gene Expression Profiling Test on Clinical Management Decisions for High-Risk Cutaneous Squamous Cell Carcinoma” (2020) SKIN The Journal of Cutaneous Medicine, 4(5), p. s64. doi:10.25251/skin.4.supp.63.